Android app Apple app link

GSK boss: Britain must reform drug pricing to become a life sciences superpower

By The Guardian   |   1 month ago
GSK boss: Britain must reform drug pricing to become a life sciences superpower

GSK's CEO Emma Walmsley is hopeful for a resolution on drug pricing with the NHS. Shares surged on higher profits. GSK aims to boost UK life sciences while facing challenges in the US market.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.